Article Information
History
- November 11, 2022.
Article Versions
- You are currently viewing Version 1 of this article (November 11, 2022 - 12:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Daniel E. Loewenstein, MD1,
- Björn Wieslander, MD PhD1,
- Einar Heiberg, PhD2,
- Jimmy Axelsson, MD1,
- Igor Klem, MD3,
- Robin Nijveldt, MD PhD4,
- Erik B. Schelbert, MSc MD5,
- Peder Sörensson, MD PhD6,
- Andreas Sigfridsson, PhD1,
- David G. Strauss, MD7,
- Raymond J. Kim, MD8,
- Brett D. Atwater, MD9,† and
- Martin Ugander, MD PhD1,10,*,†
- 1Department of Clinical Physiology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
- 2Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skane University Hospital, Lund, Sweden
- 3Division of Cardiology, Duke University Medical Center, Durham, NC, USA
- 4Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands
- 5Minneapolis Heart Institute East, Allina Health, United Hospital, St. Paul, MN, USA
- 6Department of Medicine Solna, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Solna, Stockholm, Sweden
- 7Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S Food and Drug Administration, Silver Spring, MD, USA
- 8Duke Cardiovascular Magnetic Resonance Center, Duke University Medical Center, Durham, NC, USA
- 9Section of Cardiac Electrophysiology, Inova Heart and Vascular Institute, Fairfax, VA, USA
- 10Kolling Institute, Royal North Shore Hospital, and University of Sydney, Sydney, Australia
- ↵*Correspondence: martin.ugander{at}gmail.com
↵† Equal contribution as last author